Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 05, 2017 Filed May 9, 2017 20:25 UTC |
STALLKAMP THOMAS TDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,760 | $0.00 Strike: $33.77 | $0.00 |
DisclosureSEC source: 0001124165-17-000002 · edgar.xml · derivative · entry 7 STALLKAMP THOMAS T · CIK 0001124165 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 3,760 shares Expires 2018-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2017 Filed May 9, 2017 20:25 UTC |
STALLKAMP THOMAS TDirector
|
SaleCommon Stock, $1 par value | 4,320 | $55.74 | $240,796.80 |
DisclosureSEC source: 0001124165-17-000002 · edgar.xml · nonDerivative · entry 5 STALLKAMP THOMAS T · CIK 0001124165 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,273 F1 · price: Price reflects weighted average sales price. Range of prices for transactions are $55.74 through $55.75. Full information regarding the number of shares sold at each separate price will be provided by the issuer upon request. Read SEC document |
| May 05, 2017 Filed May 9, 2017 20:25 UTC |
STALLKAMP THOMAS TDirector
|
Exercise / conversionCommon Stock, $1 par value | 4,320 | $24.27 | $104,846.40 |
DisclosureSEC source: 0001124165-17-000002 · edgar.xml · nonDerivative · entry 4 STALLKAMP THOMAS T · CIK 0001124165 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,593 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2017 Filed May 9, 2017 20:25 UTC |
STALLKAMP THOMAS TDirector
|
SaleCommon Stock, $1 par value | 3,760 | $55.74 | $209,582.40 |
DisclosureSEC source: 0001124165-17-000002 · edgar.xml · nonDerivative · entry 3 STALLKAMP THOMAS T · CIK 0001124165 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,273 F1 · price: Price reflects weighted average sales price. Range of prices for transactions are $55.74 through $55.75. Full information regarding the number of shares sold at each separate price will be provided by the issuer upon request. Read SEC document |
| May 05, 2017 Filed May 9, 2017 20:25 UTC |
STALLKAMP THOMAS TDirector
|
Exercise / conversionCommon Stock, $1 par value | 3,760 | $33.77 | $126,975.20 |
DisclosureSEC source: 0001124165-17-000002 · edgar.xml · nonDerivative · entry 2 STALLKAMP THOMAS T · CIK 0001124165 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,033 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2017 Filed May 9, 2017 20:25 UTC |
STALLKAMP THOMAS TDirector
|
SaleCommon Stock, $1 par value | 2,618 | $55.81 | $146,110.58 |
DisclosureSEC source: 0001124165-17-000002 · edgar.xml · nonDerivative · entry 1 STALLKAMP THOMAS T · CIK 0001124165 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,273 Read SEC document |
| May 02, 2017 Filed May 4, 2017 21:01 UTC |
STALLKAMP THOMAS TDirector
|
GrantStock Option (Right to Buy) · Derivative | 9,027 | $0.00 Strike: $55.68 | $0.00 |
DisclosureSEC source: 0001124165-17-000001 · edgar.xml · derivative · entry 3 STALLKAMP THOMAS T · CIK 0001124165 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,027 Underlying: Common Stock, $1 par value · 9,027 shares Expires 2027-05-02 F2 · derivative.exercise_date: The reporting person received a grant of fully vested Company stock options, subject to the terms and conditions of the applicable grant. Read SEC document |
| May 02, 2017 Filed May 4, 2017 21:01 UTC |
STALLKAMP THOMAS TDirector
|
GrantCommon Stock, $1 par value | 1,616 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001124165-17-000001 · edgar.xml · nonDerivative · entry 1 STALLKAMP THOMAS T · CIK 0001124165 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,891 F1 · price: The reporting person received a grant of 1,616 fully vested shares of common stock of Baxter International Inc. (the "Company"), subject to the terms and conditions of the applicable grant. Read SEC document |
| May 02, 2017 Filed May 4, 2017 20:57 UTC |
Mahoney Michael FDirector
|
GrantStock Option (Right to Buy) · Derivative | 9,027 | $0.00 Strike: $55.68 | $0.00 |
DisclosureSEC source: 0001533022-17-000001 · edgar.xml · derivative · entry 3 Mahoney Michael F · CIK 0001533022 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,027 Underlying: Common Stock, $1 par value · 9,027 shares Expires 2027-05-02 F2 · derivative.exercise_date: The reporting person received a grant of fully vested Company stock options, subject to the terms and conditions of the applicable grant. Read SEC document |
| May 02, 2017 Filed May 4, 2017 20:57 UTC |
Mahoney Michael FDirector
|
GrantCommon Stock, $1 par value | 1,616 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001533022-17-000001 · edgar.xml · nonDerivative · entry 1 Mahoney Michael F · CIK 0001533022 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,784 F1 · price: The reporting person received a grant of 1,616 fully vested shares of common stock of Baxter International Inc. (the "Company"), subject to the terms and conditions of the applicable grant. Read SEC document |
| May 02, 2017 Filed May 4, 2017 21:03 UTC |
STROUCKEN ALBERT P LDirector
|
GrantCommon Stock, $1 par value | 3,233 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001205438-17-000002 · edgar.xml · nonDerivative · entry 1 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,620 F1 · price: The reporting person received a grant of 3,233 fully vested shares of common stock of Baxter International Inc. (the "Company"), subject to the terms and conditions of the applicable grant. Read SEC document |
| May 02, 2017 Filed May 4, 2017 21:14 UTC |
HELLMAN PETER SDirector
|
GrantStock Option (Right to Buy) · Derivative | 9,027 | $0.00 Strike: $55.68 | $0.00 |
DisclosureSEC source: 0001107468-17-000003 · edgar.xml · derivative · entry 3 HELLMAN PETER S · CIK 0001107468 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,027 Underlying: Common Stock, $1 par value · 9,027 shares Expires 2027-05-02 F2 · derivative.exercise_date: The reporting person received a grant of fully vested Company stock options, subject to the terms and conditions of the applicable grant. Read SEC document |
| May 02, 2017 Filed May 4, 2017 21:14 UTC |
HELLMAN PETER SDirector
|
GrantCommon Stock, $1 par value | 1,616 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001107468-17-000003 · edgar.xml · nonDerivative · entry 1 HELLMAN PETER S · CIK 0001107468 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,762 F1 · price: The reporting person received a grant of 1,616 fully vested shares of common stock of Baxter International Inc. (the "Company"), subject to the terms and conditions of the applicable grant. Read SEC document |
| May 02, 2017 Filed May 4, 2017 21:02 UTC |
STORM KORNELIS J.Director
|
Tax withholdingCommon Stock, $1 par value | 970 | $55.68 | $54,009.60 |
DisclosureSEC source: 0001228779-17-000001 · edgar.xml · nonDerivative · entry 3 STORM KORNELIS J. · CIK 0001228779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,458 F3 · shares: Represents the forfeiture of shares to pay the tax liability on the 2017 annual equity grant of common stock. Read SEC document |
| May 02, 2017 Filed May 4, 2017 21:02 UTC |
STORM KORNELIS J.Director
|
GrantCommon Stock, $1 par value | 3,233 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001228779-17-000001 · edgar.xml · nonDerivative · entry 2 STORM KORNELIS J. · CIK 0001228779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,428 F2 · price: The reporting person received a grant of 3,233 fully vested shares of common stock of Baxter International Inc. (the "Company"), subject to the terms and conditions of the applicable grant. Read SEC document |
| May 02, 2017 Filed May 4, 2017 21:02 UTC |
STORM KORNELIS J.Director
|
Tax withholdingCommon Stock, $1 par value | 785 | $55.68 | $43,708.80 |
DisclosureSEC source: 0001228779-17-000001 · edgar.xml · nonDerivative · entry 1 STORM KORNELIS J. · CIK 0001228779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,195 F1 · shares: Represents the forfeiture of shares to pay the tax liability on the 2016 Restricted Stock Unit grant which vested on May 2, 2017. Read SEC document |
| May 02, 2017 Filed May 4, 2017 20:58 UTC |
Oesterle Stephen N.Director
|
GrantCommon Stock, $1 par value | 3,233 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001174532-17-000005 · edgar.xml · nonDerivative · entry 1 Oesterle Stephen N. · CIK 0001174532 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,664 F1 · price: The reporting person received a grant of 3,233 fully vested shares of common stock of Baxter International Inc. (the "Company"), subject to the terms and conditions of the applicable grant. Read SEC document |
| May 02, 2017 Filed May 4, 2017 21:00 UTC |
Shapazian Carole JDirector
|
GrantCommon Stock, $1 par value | 3,233 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001206256-17-000002 · edgar.xml · nonDerivative · entry 1 Shapazian Carole J · CIK 0001206256 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,466 F1 · price: The reporting person received a grant of 3,233 fully vested shares of common stock of Baxter International Inc. (the "Company"), subject to the terms and conditions of the applicable grant. Read SEC document |
| May 02, 2017 Filed May 4, 2017 20:52 UTC |
GAVIN JAMES R IIIDirector
|
GrantStock Option (Right to Buy) · Derivative | 9,027 | $0.00 Strike: $55.68 | $0.00 |
DisclosureSEC source: 0001220966-17-000003 · edgar.xml · derivative · entry 2 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,027 Underlying: Common Stock, $1 par value · 9,027 shares Expires 2027-05-02 F2 · derivative.exercise_date: The reporting person received a grant of fully vested Company stock options, subject to the terms and conditions of the applicable grant. Read SEC document |
| May 02, 2017 Filed May 4, 2017 20:52 UTC |
GAVIN JAMES R IIIDirector
|
GrantCommon Stock, $1 par value | 1,616 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001220966-17-000003 · edgar.xml · nonDerivative · entry 1 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,393 F1 · price: The reporting person received a grant of 1,616 fully vested shares of common stock of Baxter International Inc. (the "Company"), subject to the terms and conditions of the applicable grant. Read SEC document |
| May 02, 2017 Filed May 4, 2017 20:51 UTC |
FORSYTH JOHN DDirector
|
GrantStock Option (Right to Buy) · Derivative | 9,027 | $0.00 Strike: $55.68 | $0.00 |
DisclosureSEC source: 0001262931-17-000002 · edgar.xml · derivative · entry 2 FORSYTH JOHN D · CIK 0001262931 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,027 Underlying: Common Stock, $1 par value · 9,027 shares Expires 2027-05-02 F2 · derivative.exercise_date: The reporting person received a grant of fully vested Company stock options, subject to the terms and conditions of the applicable grant. Read SEC document |
| May 02, 2017 Filed May 4, 2017 20:51 UTC |
FORSYTH JOHN DDirector
|
GrantCommon Stock, $1 par value | 1,616 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001262931-17-000002 · edgar.xml · nonDerivative · entry 1 FORSYTH JOHN D · CIK 0001262931 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,684 F1 · price: The reporting person received a grant of 1,616 fully vested shares of common stock of Baxter International Inc. (the "Company"), subject to the terms and conditions of the applicable grant. Read SEC document |
| May 02, 2017 Filed May 4, 2017 20:48 UTC |
Chen Thomas FDirector
|
GrantCommon Stock, $1 par value | 3,233 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001360147-17-000002 · edgar.xml · nonDerivative · entry 1 Chen Thomas F · CIK 0001360147 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,216 F1 · price: The reporting person received a grant of 3,233 fully vested shares of common stock of Baxter International Inc. (the "Company"), subject to the terms and conditions of the applicable grant. Read SEC document |
| April 10, 2017 Filed Apr 12, 2017 22:01 UTC |
STROUCKEN ALBERT P LDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,280 | $0.00 Strike: $30.73 | $0.00 |
DisclosureSEC source: 0001205438-17-000001 · edgar.xml · derivative · entry 4 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 4,280 shares Expires 2017-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Stroucken with respect to the stock options granted by Baxter International Inc. to Mr. Stroucken on May 1, 2007. Read SEC document |
| April 10, 2017 Filed Apr 12, 2017 22:01 UTC |
STROUCKEN ALBERT P LDirector
|
SaleCommon Stock, $1 par value | 4,280 | $52.80 | $225,984.00 |
DisclosureSEC source: 0001205438-17-000001 · edgar.xml · nonDerivative · entry 2 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,387 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Stroucken with respect to the stock options granted by Baxter International Inc. to Mr. Stroucken on May 1, 2007. Read SEC document |
| April 10, 2017 Filed Apr 12, 2017 22:01 UTC |
STROUCKEN ALBERT P LDirector
|
Exercise / conversionCommon Stock, $1 par value | 4,280 | $30.73 | $131,524.40 |
DisclosureSEC source: 0001205438-17-000001 · edgar.xml · nonDerivative · entry 1 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Stroucken with respect to the stock options granted by Baxter International Inc. to Mr. Stroucken on May 1, 2007. Read SEC document |
| March 29, 2017 Filed Mar 30, 2017 20:12 UTC |
GAVIN JAMES R IIIDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,280 | $0.00 Strike: $30.73 | $0.00 |
DisclosureSEC source: 0001220966-17-000002 · edgar.xml · derivative · entry 3 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 4,280 shares Expires 2017-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Dr. Gavin with respect to the stock options granted by Baxter International Inc. to Dr. Gavin on May 1, 2007. Read SEC document |
| March 29, 2017 Filed Mar 30, 2017 20:12 UTC |
GAVIN JAMES R IIIDirector
|
SaleCommon Stock, $1 par value | 4,280 | $51.72 | $221,361.60 |
DisclosureSEC source: 0001220966-17-000002 · edgar.xml · nonDerivative · entry 2 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,700 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Dr. Gavin with respect to the stock options granted by Baxter International Inc. to Dr. Gavin on May 1, 2007. Read SEC document |
| March 29, 2017 Filed Mar 30, 2017 20:12 UTC |
GAVIN JAMES R IIIDirector
|
Exercise / conversionCommon Stock, $1 par value | 4,280 | $30.73 | $131,524.40 |
DisclosureSEC source: 0001220966-17-000002 · edgar.xml · nonDerivative · entry 1 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,980 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Dr. Gavin with respect to the stock options granted by Baxter International Inc. to Dr. Gavin on May 1, 2007. Read SEC document |
| March 06, 2017 Filed Mar 8, 2017 21:15 UTC |
Vibert PaulCVP, International
|
Tax withholdingCommon Stock, $1 par value | 227 | $50.68 | $11,504.36 |
DisclosureSEC source: 0001645277-17-000003 · edgar.xml · nonDerivative · entry 1 Vibert Paul · CIK 0001645277 · CVP, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,283 F1 · shares: Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of partial vesting of restricted stock granted on March 4, 2014. Read SEC document |
| March 06, 2017 Filed Mar 8, 2017 21:14 UTC |
Schabacker MarcusCVP, Chief Scientific Officer
|
Tax withholdingCommon Stock, $1 par value | 286 | $50.68 | $14,494.48 |
DisclosureSEC source: 0001645282-17-000004 · edgar.xml · nonDerivative · entry 1 Schabacker Marcus · CIK 0001645282 · CVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,602 F1 · shares: Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of partial vesting of restricted stock granted on March 4, 2014. Read SEC document |
| March 06, 2017 Filed Mar 8, 2017 21:13 UTC |
Karp CarolineCVP, Controller
|
Tax withholdingCommon Stock, $1 par value | 103 | $50.68 | $5,220.04 |
DisclosureSEC source: 0001670858-17-000003 · edgar.xml · nonDerivative · entry 1 Karp Caroline · CIK 0001670858 · CVP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,384 F1 · shares: Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of partial vesting of restricted stock granted on March 4, 2014. Read SEC document |
| March 06, 2017 Filed Mar 8, 2017 21:12 UTC |
Eyre Brik VCVP, Hospital Products
|
Tax withholdingCommon Stock, $1 par value | 400 | $50.68 | $20,272.00 |
DisclosureSEC source: 0001645572-17-000004 · edgar.xml · nonDerivative · entry 1 Eyre Brik V · CIK 0001645572 · CVP, Hospital Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,161 F1 · shares: Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of partial vesting of restricted stock granted on March 4, 2014. Read SEC document |
| March 06, 2017 Filed Mar 8, 2017 21:11 UTC |
Accogli GiuseppeCVP, Renal
|
Tax withholdingCommon Stock, $1 Par Value | 112 | $50.68 | $5,676.16 |
DisclosureSEC source: 0001678067-17-000004 · edgar.xml · nonDerivative · entry 1 Accogli Giuseppe · CIK 0001678067 · CVP, Renal 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,209 F1 · shares: Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of partial vesting of restricted stock granted on March 4, 2014. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 21:13 UTC |
Schabacker MarcusCVP, Chief Scientific Officer
|
Tax withholdingCommon Stock, $1 par value | 1,454 | $50.91 | $74,023.14 |
DisclosureSEC source: 0001645282-17-000003 · edgar.xml · nonDerivative · entry 1 Schabacker Marcus · CIK 0001645282 · CVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,889 F1 · shares: Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of partial vesting of restricted stock granted on March 3, 2015. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 21:14 UTC |
Vibert PaulCVP, International
|
Tax withholdingCommon Stock,$1 par value | 1,403 | $50.91 | $71,426.73 |
DisclosureSEC source: 0001645277-17-000002 · edgar.xml · nonDerivative · entry 1 Vibert Paul · CIK 0001645277 · CVP, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,511 F1 · shares: Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of partial vesting of restricted stock granted on March 3, 2015. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 21:11 UTC |
Mason Jeanne KCVP, Human Resources
|
Tax withholdingCommon Stock, $1 par value | 3,203 | $50.91 | $163,064.73 |
DisclosureSEC source: 0001362109-17-000003 · edgar.xml · nonDerivative · entry 1 Mason Jeanne K · CIK 0001362109 · CVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,303 F1 · shares: Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of partial vesting of restricted stock granted on March 3, 2015. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 21:12 UTC |
SACCARO JAMESCVP and CFO
|
Tax withholdingCommon Stock, $1 par value | 2,633 | $50.91 | $134,046.03 |
DisclosureSEC source: 0001593636-17-000003 · edgar.xml · nonDerivative · entry 1 SACCARO JAMES · CIK 0001593636 · CVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,325 F1 · shares: Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of partial vesting of restricted stock granted on March 3, 2015. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 21:10 UTC |
Karp CarolineCVP, Controller
|
Tax withholdingCommon Stock,$1 par value | 397 | $50.91 | $20,211.27 |
DisclosureSEC source: 0001670858-17-000002 · edgar.xml · nonDerivative · entry 1 Karp Caroline · CIK 0001670858 · CVP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,487 F1 · shares: Represents an aggregate of 213 shares of Baxter International Inc. (the "Company") common stock and 184 shares of Company common stock forfeited by the reporting person to cover the payment of taxes incurred as a result of partial vesting of restricted stock granted on March 3, 2015 and March 3, 2016, respectively. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 21:10 UTC |
Eyre Brik VCVP, Hospital Products
|
Tax withholdingCommon Stock,$1 par value | 2,180 | $50.91 | $110,983.80 |
DisclosureSEC source: 0001645572-17-000003 · edgar.xml · nonDerivative · entry 1 Eyre Brik V · CIK 0001645572 · CVP, Hospital Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,561 F1 · shares: Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of partial vesting of restricted stock granted on March 3, 2015. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 21:08 UTC |
Accogli GiuseppeCVP, Renal
|
Tax withholdingCommon Stock, $1 par value | 819 | $50.91 | $41,695.29 |
DisclosureSEC source: 0001678067-17-000003 · edgar.xml · nonDerivative · entry 1 Accogli Giuseppe · CIK 0001678067 · CVP, Renal 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,322 F1 · shares: Represents an aggregate of 523 shares of Baxter International Inc. (the "Company") common stock and 296 shares of Company common stock forfeited by the reporting person to cover the payment of taxes incurred as a result of partial vesting of restricted stock granted on March 3, 2015 and March 3, 2016, respectively. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 21:28 UTC |
Mason Jeanne KCVP, Human Resources
|
GrantStock Option (Right to Buy) · Derivative | 74,866 | $0.00 Strike: $50.77 | $0.00 |
DisclosureSEC source: 0001362109-17-000002 · edgar.xml · derivative · entry 1 Mason Jeanne K · CIK 0001362109 · CVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,866 Underlying: Common Stock, $1 par value · 74,866 shares Expires 2027-03-02 F1 · derivative.exercise_date: The option becomes exercisable in three equal annual installments beginning on the first anniversary of the date of the grant. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 22:06 UTC |
ALMEIDA JOSE EDirector · Chairman, President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 534,759 | $0.00 Strike: $50.77 | $0.00 |
DisclosureSEC source: 0001216761-17-000004 · edgar.xml · derivative · entry 1 ALMEIDA JOSE E · CIK 0001216761 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 534,759 Underlying: Common Stock, $1 par value · 534,759 shares Expires 2027-03-02 F1 · derivative.exercise_date: The option becomes exercisable in three equal annual installments beginning on the first anniversary of the date of the grant. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 21:39 UTC |
Martin SeanCVP and General Counsel
|
GrantStock Option (Right to Buy) · Derivative | 85,561 | $0.00 Strike: $50.77 | $0.00 |
DisclosureSEC source: 0001500332-17-000004 · edgar.xml · derivative · entry 3 Martin Sean · CIK 0001500332 · CVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,561 Underlying: Common Stock, $1 par value · 85,561 shares Expires 2027-03-02 F3 · derivative.exercise_date: The option becomes exercisable in three equal annual installments beginning on the first anniversary of the date of the grant. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 21:39 UTC |
Martin SeanCVP and General Counsel
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $50.77 | $0.00 |
DisclosureSEC source: 0001500332-17-000004 · edgar.xml · derivative · entry 2 Martin Sean · CIK 0001500332 · CVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock, $1 par value · 150,000 shares Expires 2027-03-02 F2 · derivative.exercise_date: The option becomes exercisable on March 2, 2020. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 21:39 UTC |
Martin SeanCVP and General Counsel
|
GrantCommon Stock, $1 par value | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001500332-17-000004 · edgar.xml · nonDerivative · entry 1 Martin Sean · CIK 0001500332 · CVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F1 · shares: The restricted stock units will vest on March 2, 2020. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 21:35 UTC |
Schabacker MarcusCVP, Chief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 42,781 | $0.00 Strike: $50.77 | $0.00 |
DisclosureSEC source: 0001645282-17-000002 · edgar.xml · derivative · entry 1 Schabacker Marcus · CIK 0001645282 · CVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,781 Underlying: Common Stock,$1 par value · 42,781 shares Expires 2027-03-02 F1 · derivative.exercise_date: The option becomes exercisable in three equal annual installments beginning on the first anniversary of the date of the grant. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 21:33 UTC |
SACCARO JAMESCVP and CFO
|
GrantStock Option (Right to Buy) · Derivative | 117,647 | $0.00 Strike: $50.77 | $0.00 |
DisclosureSEC source: 0001593636-17-000002 · edgar.xml · derivative · entry 1 SACCARO JAMES · CIK 0001593636 · CVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,647 Underlying: Common Stock,$1 par value · 117,647 shares Expires 2027-03-02 F1 · derivative.exercise_date: The option becomes exercisable in three equal annual installments beginning on the first anniversary of the date of the grant. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 21:27 UTC |
Karp CarolineCVP, Controller
|
GrantStock Option (Right to Buy) · Derivative | 16,043 | $0.00 Strike: $50.77 | $0.00 |
DisclosureSEC source: 0001670858-17-000001 · edgar.xml · derivative · entry 2 Karp Caroline · CIK 0001670858 · CVP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,043 Underlying: Common Stock, $1 par value · 16,043 shares Expires 2027-03-02 F2 · derivative.exercise_date: The option becomes exercisable in three equal annual installments beginning on the first anniversary of the date of the grant. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 21:27 UTC |
Karp CarolineCVP, Controller
|
GrantCommon Stock,$1 par value | 1,508 | $0.00 | $0.00 |
DisclosureSEC source: 0001670858-17-000001 · edgar.xml · nonDerivative · entry 1 Karp Caroline · CIK 0001670858 · CVP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,885 F1 · shares: The reporting person received a grant of 1,508 restricted stock units which will vest in three equal installments beginning on the first anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.